Literature DB >> 2478999

Activation of proteases in cerulein-induced pancreatitis.

H Yamaguchi1, T Kimura, K Mimura, H Nawata.   

Abstract

The activation of zymogen proteases and lysosomal enzyme cathepsin B in the pancreas was investigated in cerulein-induced pancreatitis in rats. Acute pancreatitis was induced by two intraperitoneal injections of 40 micrograms/kg of body weight of cerulein at intervals of 1 h. After the first cerulein injection, the active trypsin and elastase contents in the pancreas tissues significantly increased, and reached the highest level at 3 h after the first injection, followed by peaks at 5 h in the serum amylase and lipase levels and the pancreas wet weight. Cathepsin B contents in pancreas tissues showed a parallel increase with active zymogen enzymes during the first 3 h of pancreatitis. These findings may suggest that the intracellular activation of trypsinogen is an important step in the development of cerulein-induced acute pancreatitis and that cathepsin B plays a role in the activation of trypsinogen in pancreatic acinar cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478999     DOI: 10.1097/00006676-198910000-00007

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  34 in total

1.  The role of phospholipase A2 in pancreatic acinar cell injury.

Authors:  A J Hietaranta; Z G Lászik; H J Aho; P T Kortesuo; T J Nevalainen
Journal:  Int J Pancreatol       Date:  1991-02

2.  Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis.

Authors:  D I Heath; C Wilson; A M Gudgeon; A Jehanli; A Shenkin; C W Imrie
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

3.  High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial.

Authors:  R Berling; S Genell; K Ohlsson
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

4.  Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats.

Authors:  W Kimura; J Mössner
Journal:  Int J Pancreatol       Date:  1996-12

5.  Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs.

Authors:  John F Eisses; Angela Criscimanna; Zachary R Dionise; Abrahim I Orabi; Tanveer A Javed; Sheharyar Sarwar; Shunqian Jin; Lili Zhou; Sucha Singh; Minakshi Poddar; Amy W Davis; Akif Burak Tosun; John A Ozolek; Mark E Lowe; Satdarshan P Monga; Gustavo K Rohde; Farzad Esni; Sohail Z Husain
Journal:  Am J Pathol       Date:  2015-10-23       Impact factor: 4.307

6.  Trypsinogen activation peptides (TAP) in peritoneal fluid as predictors of late histopathologic injury in necrotizing pancreatitis of the rat.

Authors:  J Schmidt; E Ryschich; H P Sinn; S Maksan; C Herfarth; E Klar
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

7.  Effect of proton pump inhibitor on amylase release from isolated pancreatic acini.

Authors:  Jia Cai; Wei Zhou; He-Sheng Luo; L V Peng
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-01       Impact factor: 2.416

8.  Effect of endothelin-1 receptor antagonists on histological and ultrastructural changes in the pancreas and trypsinogen activation in the early course of caerulein-induced acute pancreatitis in rats.

Authors:  Anna Andrzejewska; Jan-W Dlugosz; Albert Augustynowicz
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

9.  Nonesterified fatty acids in acute cerulein-induced pancreatitis in the rat. Are they really deleterious in vivo?

Authors:  F Paye; J Chariot; G Molas; J Benessiano; C Rozé
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

Review 10.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.